Cargando…

Role of Hyperglycemia-Induced Advanced Glycation End Product (AGE) Accumulation in Atherosclerosis

There is a growing body of evidence that cumulative hyperglycemic exposure plays a central role in the development and progression of atherosclerotic cardiovascular disease in diabetic patients. Monosaccharides, such as glucose, fructose, and glyceraldehyde can react non-enzymatically with amino gro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamagishi, Sho-ichi, Matsui, Takanori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japanese College of Angiology / The Japanese Society for Vascular Surgery / Japanese Society of Phlebology 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200622/ https://www.ncbi.nlm.nih.gov/pubmed/30402172 http://dx.doi.org/10.3400/avd.ra.18-00070

Ejemplares similares

Role of receptor for advanced glycation end products (RAGE) in liver disease
por: Yamagishi, Sho-ichi, et al.
Publicado: (2015)

Advanced glycation end products, oxidative stress and diabetic nephropathy
por: Yamagishi, Sho-ichi, et al.
Publicado: (2010)

Crosstalk between advanced glycation end products (AGEs)-receptor RAGE axis and dipeptidyl peptidase-4-incretin system in diabetic vascular complications
por: Yamagishi, Sho-ichi, et al.
Publicado: (2015)

Aqueous Extract of Glucoraphanin-Rich Broccoli Sprouts Inhibits Formation of Advanced Glycation End Products and Attenuates Inflammatory Reactions in Endothelial Cells
por: Sotokawauchi, Ami, et al.
Publicado: (2018)

N-butanol extracts of Morinda citrifolia suppress advanced glycation end products (AGE)-induced inflammatory reactions in endothelial cells through its anti-oxidative properties
por: Ishibashi, Yuji, et al.
Publicado: (2017)

Predictive ability of serum advanced glycation end products at 11 to 13 weeks of gestation for early-onset preeclampsia
por: Goto, Minako, et al.
Publicado: (2022)

Cancer Malignancy Is Enhanced by Glyceraldehyde-Derived Advanced Glycation End-Products
por: Takino, Jun-Ichi, et al.
Publicado: (2010)

Association of advanced glycation end products with sarcopenia and frailty in chronic kidney disease
por: Yabuuchi, Junko, et al.
Publicado: (2020)

Advanced glycation end products potentiate citrated plasma-evoked oxidative and inflammatory reactions in endothelial cells by up-regulating protease-activated receptor-1 expression
por: Ishibashi, Yuji, et al.
Publicado: (2014)

Advanced glycation end products evoke endothelial cell damage by stimulating soluble dipeptidyl peptidase-4 production and its interaction with mannose 6-phosphate/insulin-like growth factor II receptor
por: Ishibashi, Yuji, et al.
Publicado: (2013)

Pathological Role of Receptor for Advanced Glycation End Products in Calcified Aortic Valve Stenosis
por: Saku, Kosuke, et al.
Publicado: (2020)

DNA aptamer raised against receptor for advanced glycation end products suppresses renal tubular damage and improves insulin resistance in diabetic mice
por: Sotokawauchi, Ami, et al.
Publicado: (2021)

DNA-Aptamer Raised against Receptor for Advanced Glycation End Products Improves Survival Rate in Septic Mice
por: Koga, Yoshinori, et al.
Publicado: (2021)

Insulin resistance is an independent correlate of high serum levels of advanced glycation end products (AGEs) and low testosterone in non-diabetic men
por: Tahara, Nobuhiro, et al.
Publicado: (2010)

Association of advanced glycation end products, evaluated by skin autofluorescence, with lifestyle habits in a general Japanese population
por: Isami, Fumiyuki, et al.
Publicado: (2018)

Assessment of the Concentrations of Various Advanced Glycation End-Products in Beverages and Foods That Are Commonly Consumed in Japan
por: Takeuchi, Masayoshi, et al.
Publicado: (2015)

The Contribution of Advanced Glycation End product (AGE) accumulation to the decline in motor function
por: Drenth, Hans, et al.
Publicado: (2016)

Hyperglycemia and advanced glycation end products (AGEs) suppress the differentiation of 3T3-L1 preadipocytes
por: Chang, Chia-Chu, et al.
Publicado: (2017)

Association between Subclinical Atherosclerosis Markers and the Level of Accumulated Advanced Glycation End-Products in the Skin of Patients with Diabetes
por: Ninomiya, Hiroyo, et al.
Publicado: (2018)

Accumulation of advanced glycation end products in intensive care patients
por: Greven, WL, et al.
Publicado: (2008)

Accumulation of Advanced Glycation End-Products in the Body and Dietary Habits
por: Zawada, Agnieszka, et al.
Publicado: (2022)

Positive Association Between Serum Level of Glyceraldehyde-Derived Advanced Glycation End Products and Vascular Inflammation Evaluated by [(18)F]Fluorodeoxyglucose Positron Emission Tomography
por: Tahara, Nobuhiro, et al.
Publicado: (2012)

Atorvastatin Reduces Proteinuria in Non-Diabetic Chronic Kidney Disease Patients Partly via Lowering Serum Levels of Advanced Glycation End Products (AGEs)
por: Nakamura, Tsukasa, et al.
Publicado: (2010)

A Role for Advanced Glycation End Products in Molecular Ageing
por: Zgutka, Katarzyna, et al.
Publicado: (2023)

Dietary Advanced Glycation End Products and Aging
por: Luevano-Contreras, Claudia, et al.
Publicado: (2010)

Role of advanced glycation end products on vascular smooth muscle cells under diabetic atherosclerosis
por: Mao, Lin, et al.
Publicado: (2022)

Accumulation of advanced glycation end (AGEs) products in intensive care patients: an observational, prospective study
por: Greven, Wendela L, et al.
Publicado: (2010)

The Role of Advanced Glycation End Products on Dyslipidemia
por: Vekic, Jelena, et al.
Publicado: (2023)

Abstract: Perceived Facial Aging: The Role of AGES (Advanced Glycation End Products)
por: Lee, Jonathan Y., et al.
Publicado: (2017)

Dietary Advanced Glycation End Products: Their Role in the Insulin Resistance of Aging
por: Portero-Otin, Manuel, et al.
Publicado: (2023)

Relationship between Advanced Glycation End Products and Plaque Progression in Patients with Acute Coronary Syndrome: The JAPAN-ACS Sub-study
por: Fukushima, Yoshifumi, et al.
Publicado: (2013)

Advanced Glycation End-Products in Skeletal Muscle Aging
por: Olson, Lucas C., et al.
Publicado: (2021)

Relationship between advanced glycation end-product accumulation in the skin and pulmonary function
por: Kubo, Akira, et al.
Publicado: (2018)

Hyperglycemia-Induced Reactive Oxygen Species Increase Expression of the Receptor for Advanced Glycation End Products (RAGE) and RAGE Ligands
por: Yao, Dachun, et al.
Publicado: (2010)

Neuropathy induced by exogenously administered advanced glycation end‐products in rats
por: Nishizawa, Yusuke, et al.
Publicado: (2010)

Hyperglycemia-related advanced glycation end-products is associated with the altered phosphatidylcholine metabolism in osteoarthritis patients with diabetes
por: Zhang, Weidong, et al.
Publicado: (2017)

Receptor for Advanced Glycation End Products (RAGE) Deficiency Attenuates the Development of Atherosclerosis in Diabetes
por: Soro-Paavonen, Aino, et al.
Publicado: (2008)

Advanced glycation end products and the absence of premature atherosclerosis in glycogen storage disease Ia
por: den Hollander, N. C., et al.
Publicado: (2007)

Plasma Advanced Glycation End Products and Dicarbonyl Compounds Are Not Associated with Coronary Atherosclerosis in Athletes
por: BERGE, KRISTIAN, et al.
Publicado: (2023)

N(ω)-(Carboxymethyl)arginine Is One of the Dominant Advanced Glycation End Products in Glycated Collagens and Mouse Tissues
por: Kinoshita, Sho, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0td77eqn09n894neqsg2elh16q